Omeclamox-Pak is an FDA-approved prescription drug that combines several drug therapies for treatment of Helicobacter pylori infection and duodenal ulcer disease.
Cumberland will promote the drug to its gastroenterologists, and Pernix will promote the produce to its primary care physicians.
More Articles on Gastroenterology:
gMed Announcces gInsights Business & Clinical Intelligence Platform
Stay Competitive: 5 Enhancements for GI/Endoscopy Groups
gGastro EHR System Receives Full EHR Certification
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
